1. Home
  2. GM vs TAK Comparison

GM vs TAK Comparison

Compare GM & TAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GM

General Motors Company

N/A

Current Price

$86.34

Market Cap

72.1B

ML Signal

N/A

Logo Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

TAK

Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

N/A

Current Price

$21.19

Market Cap

59.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GM
TAK
Founded
1908
1781
Country
United States
Japan
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
72.1B
59.8B
IPO Year
2010
2007

Fundamental Metrics

Financial Performance
Metric
GM
TAK
Price
$86.34
$21.19
Analyst Decision
Buy
Strong Buy
Analyst Count
24
3
Target Price
★ $101.09
$22.74
AVG Volume (30 Days)
★ 7.8M
3.0M
Earning Date
10-20-2026
10-29-2026
Dividend Yield
0.81%
★ 1.16%
EPS Growth
N/A
★ N/A
EPS
★ 7.94
N/A
Revenue
★ $185,019,000,000.00
N/A
Revenue This Year
$0.71
$4.54
Revenue Next Year
$1.68
$2.37
P/E Ratio
★ $11.17
$41.25
Revenue Growth
N/A
★ N/A
52 Week Low
$67.06
$13.91
52 Week High
$93.70
$21.73

Technical Indicators

Market Signals
Indicator
GM
TAK
Relative Strength Index (RSI) 52.85 67.52
Support Level $84.16 $17.73
Resistance Level $88.02 $21.73
Average True Range (ATR) 2.72 0.37
MACD 0.36 -0.01
Stochastic Oscillator 60.34 76.18

Price Performance

Historical Comparison
GM
TAK

About GM General Motors Company

General Motors Co. emerged from the bankruptcy of General Motors Corp. (old GM) in July 2009. GM has eight brands and operates under three segments: GM North America, GM International, and GM Financial. The United States now has four brands instead of eight under old GM. The company regained its US market share leadership in 2022, after losing it to Toyota due to the chip shortage in 2021. 2025 US share was 17.4%, up 60 basis points from 2024. The Cruise autonomous vehicle arm, which GM now owns outright, previously operated driverless geofenced AV robotaxi services in San Francisco and other cities, but after a 2023 accident, GM decided that it will focus on personal AVs. GM Financial became the company's captive finance arm in 2010 via the purchase of AmeriCredit.

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.5 trillion in fiscal 2025. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with about 50% from the US, 10% from Japan, 25% from Europe, and 15% from Canada.

Share on Social Networks: